Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arzoxifene for Osteoporosis in Korean Postmenopausal Women
NCT00767299Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arzoxifene in osteoporosis, sponsored by Eli Lilly and Company. Started Dec 2008; status: completed.
02
Drugs
arzoxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00767299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767299.